المؤلفون: Passiglia, F, Pilotto, S, Facchinetti, F, Bertolaccini, L, Del Re, M, Ferrara, R, Franchina, T, Malapelle, U, Menis, J, Passaro, A, Ramella, S, Rossi, G, Trisolini, R, Novello, S

المساهمون: Passiglia, F, Pilotto, S, Facchinetti, F, Bertolaccini, L, Del Re, M, Ferrara, R, Franchina, T, Malapelle, U, Menis, J, Passaro, A, Ramella, S, Rossi, G, Trisolini, R, Novello, S

مصطلحات موضوعية: Clinical practice guidelines, Metastatic disease, Non-small cell lung cancer, Recommendations, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Humans, Italy, Lung Neoplasms, Medical Oncology, Societies, Medical, Practice Guidelines as Topic

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31918343; info:eu-repo/semantics/altIdentifier/wos/WOS:000521119200004; volume:146; firstpage:102858; lastpage:102868; numberofpages:11; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11562/1030198Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85077438119

الإتاحة: https://doi.org/10.1016Test/j.critrevonc.2019.102858
http://hdl.handle.net/11562/1030198Test

المؤلفون: Pasello G., Pavan A., Attili I., Bortolami A., Bonanno L., Menis J., Conte P., Guarneri V.

المساهمون: Pasello, G., Pavan, A., Attili, I., Bortolami, A., Bonanno, L., Menis, J., Conte, P., Guarneri, V.

مصطلحات موضوعية: Immune checkpoint inhibitor, Immunotherapy, Non-small cell lung cancer, NSCLC, Real-world evidence, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung, Human, Lung Neoplasm, Programmed Cell Death 1 Receptor, Randomized Controlled Trials as Topic

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32446182; info:eu-repo/semantics/altIdentifier/wos/WOS:000540249800005; volume:87; firstpage:102031; numberofpages:12; journal:CANCER TREATMENT REVIEWS; http://hdl.handle.net/11577/3345865Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85084796370

الإتاحة: https://doi.org/10.1016Test/j.ctrv.2020.102031
http://hdl.handle.net/11577/3345865Test

المؤلفون: Hendriks L. E. L., Menis J., De Ruysscher D. K. M., Reck M.

المساهمون: Hendriks, L. E. L., Menis, J., De Ruysscher, D. K. M., Reck, M.

مصطلحات موضوعية: Immune checkpoint inhibitor, NSCLC, Radiotherapy, SCLC

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32127183; info:eu-repo/semantics/altIdentifier/wos/WOS:000509465700009; volume:15; issue:2; firstpage:166; lastpage:169; numberofpages:4; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11577/3330772Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85078091108; https://www.journals.elsevier.com/journal-of-thoracic-oncologyTest/

الإتاحة: https://doi.org/10.1016Test/j.jtho.2019.12.106
http://hdl.handle.net/11577/3330772Test
https://www.journals.elsevier.com/journal-of-thoracic-oncologyTest/

المؤلفون: Menis J., Reck M.

المساهمون: Menis, J., Reck, M.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32093850; info:eu-repo/semantics/altIdentifier/wos/WOS:000516801100011; volume:15; issue:3; firstpage:308; lastpage:310; numberofpages:3; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11577/3330773Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85079661652; https://www.journals.elsevier.com/journal-of-thoracic-oncologyTest/

الإتاحة: https://doi.org/10.1016Test/j.jtho.2019.11.031
http://hdl.handle.net/11577/3330773Test
https://www.journals.elsevier.com/journal-of-thoracic-oncologyTest/

المؤلفون: Menis, J., Bironzo, P., Radj, G., Greillier, L., Monnet, I., Livi, L., Young, R., Decroisette, C., Cloarec, N., Robinet, G., Schott, R., Califano, Raffaele, De Marinis, F., Mauer, M., Pochesci, A., Silva, M., Caramella, C., Dingemans, A. M., Dive, C., Besse, B.

المساهمون: Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy

العلاقة: https://dx.doi.org/10.1016Test/j.annonc.2020.10.494; Menis J, Bironzo P, Radj G, Greillier L, Monnet I, Livi L, et al. 9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994). Annals of Oncology. 2020;31:S1420-S.; http://hdl.handle.net/10541/623698Test; Annals of Oncology

الإتاحة: https://doi.org/10.1016Test/j.annonc.2020.10.494
http://hdl.handle.net/10541/623698Test

المؤلفون: Menis J., Levra M. G., Novello S.

المساهمون: Menis, J., Levra, M.G., Novello, S.

العلاقة: volume:2; issue:1; firstpage:23; lastpage:39; numberofpages:17; journal:TRANSLATIONAL LUNG CANCER RESEARCH; http://hdl.handle.net/2318/1675627Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84893872278

الإتاحة: https://doi.org/10.3978Test/j.issn.2218-6751.2012.12.04
http://hdl.handle.net/2318/1675627Test

المؤلفون: O'Brien, M.E.R., Gaafar, R., Hasan, B., Menis, J., Cufer, T., Popat, S., Woll, P.J., Surmont, V., Georgoulias, V., Montes, A., Blackhall, F., Hennig, I., Schmid-Bindert, G., Baas, P., EORTC-LCG, .

وصف الملف: text

العلاقة: https://eprints.whiterose.ac.uk/100048/3/MAPPING%20tables%20%2526%20figs.pdfTest; https://eprints.whiterose.ac.uk/100048/4/MAPPING_draft%209.4.2015.pdfTest; O'Brien, M.E.R., Gaafar, R., Hasan, B. et al. (12 more authors) (2015) Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064). European Journal of Cancer, 51 (12). pp. 1511-1528. ISSN 0959-8049

الإتاحة: https://doi.org/10.1016Test/j.ejca.2015.04.026
https://eprints.whiterose.ac.uk/100048Test/
https://eprints.whiterose.ac.uk/100048/3/MAPPING%20tables%20%2526%20figs.pdfTest
https://eprints.whiterose.ac.uk/100048/4/MAPPING_draft%209.4.2015.pdfTest

المؤلفون: Menis, J., Macerelli, M., Follador, A., De Maglio, G., Valent, F., Bolzonello, S., De Carlo, E., Pagani, L., Ciani, S., Barducci, M.C., Pizzolitto, S., Fasola, G.

المصدر: Annals of Oncology ; volume 26, page vi81 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1093/annonc/mdv343.27Test
https://api.elsevier.com/content/article/PII:S0923753419534561?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753419534561?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/26/suppl_6/vi/6681821/mdv343.27.pdfTest

المؤلفون: Besse, B., Menis, J., Adam, J., Dziadziuszko, R., Hasan, B., Lacroix, L., Peters, S., Lacombe, D.A., O'Brien, M., Stahel, R.A.

المصدر: Annals of Oncology ; volume 26, page i29 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1093/annonc/mdv050.47Test
https://api.elsevier.com/content/article/PII:S0923753419555521?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753419555521?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/26/suppl_1/i44/6675993/mdv050.47.pdfTest

المؤلفون: O'Brien, M.E.R., Gaafar, R., Hasan, B., Menis, J., Cufer, T., Popat, S., Woll, P., Surmont, V., Georgoulias, V., Montes, A., Blackhall, F., Hennig, I., Schmid-Bindert, G., Baas, P.

المصدر: Annals of Oncology ; volume 25, page iv435 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1093/annonc/mdu349.23Test
https://api.elsevier.com/content/article/PII:S0923753419526667?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753419526667?httpAccept=text/plainTest
http://academic.oup.com/annonc/article-pdf/25/suppl_4/iv435/9691589/mdu349.23.pdfTest